Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and usability testing of a mindfulness-based smoking cessation app for adults with low income: "It's helped me to not react and grab a cigarette".

Journal of health psychology·2026
Same author

Understanding capability, opportunity, and motivation for at-home COVID-19 testing in underserved populations during the pandemic.

Translational behavioral medicine·2026
Same author

Antecedents and consequences of different indicators of engagement with a digital intervention for tobacco cessation.

NPJ digital medicine·2026
Same author

Mixed-Method Formative Evaluation and Cultural Adaptation of Digital Health Communication Content and Delivery Promoting Lung Cancer Screening Shared Decision-Making.

Cancer control : journal of the Moffitt Cancer Center·2026
Same author

Cost-Effectiveness of Smoking Cessation Among Survivors of Cervical Intraepithelial Neoplasia or Cervical Cancer.

JAMA network open·2026
Same author

Cost-effectiveness analysis of a text message system for COVID-19 testing for K-12 school communities.

Journal of the Pediatric Infectious Diseases Society·2026

Related Experiment Video

Updated: Jul 16, 2026

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

Smoking cessation 3: multicomponent interventions.

Ludmila Cofta-Woerpel1, Kelli L Wright, David W Wetter

  • 1Department of Behavioral Science, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. lcwoerpel@mdanderson.org

Behavioral Medicine (Washington, D.C.)
|March 14, 2007
PubMed
Summary

Multicomponent interventions combining behavioral and pharmacological therapies significantly increase smoking cessation success. These flexible models cater to diverse patient needs and clinical settings for effective tobacco dependence treatment.

Related Experiment Videos

Last Updated: Jul 16, 2026

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

Area of Science:

  • Public Health
  • Behavioral Medicine
  • Addiction Science

Background:

  • Tobacco dependence is a major public health concern requiring effective cessation strategies.
  • Single-component interventions often yield limited success in smoking cessation.
  • Combining behavioral and pharmacological approaches enhances treatment efficacy.

Purpose of the Study:

  • To review multicomponent interventions for smoking cessation.
  • To present adaptable models for implementing these interventions.
  • To guide clinicians in selecting appropriate cessation programs.

Main Methods:

  • Review of existing literature on smoking cessation interventions.
  • Development of brief and multiple-session intervention models.
  • Discussion of tailoring interventions to patient and setting.

Main Results:

  • Multicomponent interventions demonstrate higher abstinence rates than single therapies.
  • Flexible models accommodate various clinical settings and clinician types.
  • Patient-centered tailoring improves intervention applicability and effectiveness.

Conclusions:

  • Multicomponent interventions are recommended for tobacco dependence treatment.
  • Adaptable models facilitate the integration of evidence-based cessation strategies.
  • Personalized intervention selection optimizes patient outcomes in smoking cessation programs.